期刊文献+

肥厚型心肌病类缺血样强化的MRI特征及临床价值 被引量:12

MRI characteristics and clinical value of hypertrophic cardiomyopathy with scar-like late enhancement
原文传递
导出
摘要 目的探讨肥厚型心肌病(HCM)类缺血样强化方式的发生率、MRI影像特征及临床价值。方法回顾性分析2009年10月至2013年12月在我院经心脏磁共振(CMR)确诊为HCM患者1411例,明确有延迟强化的患者465例,其中类缺血样强化(以心内膜下强化为突出改变)24例。CMR图像经后处理分析,计算左心室射血分数(LVEF)和心内膜下钆对比剂的延迟强化(LGE)体积分数,按照美国心脏学会(AHA)17节段划分,统计心脏强化的节段分布情况。搜集其门诊及住院临床资料,并对这些患者进行门诊或电话随访。主要不良心血管事件(MACE)包括恶性室性心律失常及心力衰竭。采用Pearson相关性分析评价LVEF与心内膜下LGE体积分数的相关性,独立样本t检验比较左心室流出道梗阻组与非梗阻组的心内膜下延迟强化体积分数,Kaplan-Meier生存曲线比较类缺血样强化组与其他形式强化组的预后。结果类缺血样强化患者的发生率为0.05%(24/465)。流出道梗阻患者10例,非梗阻患者14例。患者平均LVEF值为(56.20±3.60)%,心内膜下平均LGE体积分数为(14.52±12.73)%。类缺血样强化最常见于14节段(各10例),其次依次是9、15(各8例)和3、8、16节段(各7例),这些节段主要分布于左心室室间隔及心尖部。LVEF值与心内膜下LGE体积分数呈负相关(r=-0.85,P<0.05)。梗阻患者心内膜下LGE体积分数(6.81±3.35)%低于非梗阻患者(21.55±13.52)%,差异具有统计学意义(t=-3.91,P=0.01)。所有延迟强化HCM患者的平均随访时间为(4.25±1.35)年,类缺血样强化患者的无事件生存率明显低于其余强化HCM患者(P<0.001)。结论类缺血样强化是HCM的特殊强化类型,其预后较其他延迟强化患者差,类缺血样延迟强化量与LVEF值和左心室流出道梗阻相关。 Objective To explore the prevalence, MRI characteristics and clinical evaluation of hypertrophic cardiomyopathy(HCM) patients with infarct-like late enhancement(LGE). Methods HCM patients were diagnosed via cardiac magnetic resonance(CMR) from October, 2009 to December, 2013. 1 411 HCM patients were diagnosed via CMR, 465 patients with LGE, of which 24 patients with infarct-like LGE (primarily in the subendocardium). Clinical and MRI data of patients demonstrating infarct-like LGE were retrospectively analyzed. All the HCM patients with LGE were followed up in the clinic or by telephone interview. Major adverse cardiovascular events(MACE) were defined as malignant ventricular arrhythmia events, including sudden cardiac death, ventricular tachycardia/fibrillation, implantable cardioverter defibrillator(ICD) discharge and heart failure events, including death from heart failure, heart transplantation. The correlation between left ventricle ejection fraction and subendocardial LGE volume fraction was evaluated by Pearson correlation analysis. Comparison of subendocardial LGE volume fraction between obstructed and non-obstructed left ventricular outflow tract (LVOT) group was performed using independent sample t test. Prognosis of patients with infarct-like LGE and other LGE patterns was compared using Kaplan-Meier curves. Results The prevalence of infarct-like LGE were 0.05%(24/465) among patients with LGE. Mean left venricle ejection fraction(LVEF) was (56.20±3.60)% and mean LGE volume fraction was (14.52±12.73) %. According to the American Heart Association (AHA) 17-segment model, infarct-like LGE was most frequent in 14 segment (10 patients) , followed by 9, 15 (8 patients, respectively) and 3, 8, 16 (7 patients, respectively) segments, mainly distributed in left ventricular septum and apical portion. EF value was inversely correlated with mean LGE volume fraction(r=-0.85, P<0.05).Mean follow up time was (4.25±1.35) years for all the HCM patients with LGE, and event-free survival rate was lower in HCM patients
出处 《中华放射学杂志》 CAS CSCD 北大核心 2018年第12期903-907,共5页 Chinese Journal of Radiology
基金 国家自然科学基金(81620108015) 首都临床特色应用研究项目基金(Z161100000516110).
关键词 心肌病 肥厚性 磁共振成像 延迟强化 Cardiomyopathy, hypertrophic Magnetic resonance imaging Late enhancement
  • 相关文献

参考文献3

二级参考文献35

  • 1赵世华,闫朝武,杨敏福,陆敏杰,蒋世良,李世国,张岩,刘琼,刘玉清,何作祥.磁共振心肌灌注延迟增强与核素心肌灌注/代谢显像识别存活心肌对比研究[J].中华心血管病杂志,2006,34(12):1072-1076. 被引量:26
  • 2闫朝武,赵世华,陆敏杰,蒋世良,韦云青,李世国,祁晓欧,张岩,刘玉清.左室心肌致密化不全的临床特征和磁共振成像表现[J].中华心血管病杂志,2006,34(12):1081-1084. 被引量:52
  • 3Rickers C,Wilke NM,Jerosch-Herold M,et al.Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.Circulation,2005,112:855-861. 被引量:1
  • 4Moon JC,Fisher NG,McKenna WJ,et al.Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.Heart,2004,90:645-649. 被引量:1
  • 5Klues HG,Schiffers A,Maron BJ.Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy:morphologic observations and significance as assessed by two-dimensiomal echocardiography in 600 patients.J Am Coll Cardiol,1995,26:1699-1708. 被引量:1
  • 6Dimitrow PP,Klimeczek P,Vliegenthart R,et al.Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging:comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.Int J Cardiovasc Imaging,2008,24:77-83. 被引量:1
  • 7Choudhury L,Mahrholdt H,Wagner A,et al.Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.J Am Coll Cardiol,2002,40:2156-2164. 被引量:1
  • 8Bogaert J,Goldstein M,Tannouri F,et al.Original report:late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.A JR,2003,180:981-985. 被引量:1
  • 9Tsukihashi H,Ishibashi Y,Shimada T,et al.Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy.J Cardiol,1994,24:185-191. 被引量:1
  • 10Koito H,Suzuki J,Nakamori H,et al.Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta-acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy.J Cardiol,1995,25:163-170. 被引量:1

共引文献32

同被引文献68

引证文献12

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部